Page last updated: 2024-11-05

thiotepa and Lassitude

thiotepa has been researched along with Lassitude in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research Excerpts

ExcerptRelevanceReference
"From a randomized study in high-risk breast cancer patients on the efficacy of high-dose versus standard-dose adjuvant chemotherapy, late effects on cognitive functioning were analyzed by neuropsychological tests."2.70Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. ( Boogerd, W; Hamburger, HL; Muller, MJ; Schagen, SB; van Dam, FS, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schagen, SB1
Hamburger, HL1
Muller, MJ1
Boogerd, W1
van Dam, FS1

Trials

1 trial available for thiotepa and Lassitude

ArticleYear
Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.
    Journal of neuro-oncology, 2001, Volume: 51, Issue:2

    Topics: Alpha Rhythm; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Carboplatin

2001